An audit of patients who have received imiquimod cream 5% for the treatment of anogenital warts. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


An audit of patients who have received imiquimod cream 5% for the treatment of anogenital warts.

Int J STD AIDS. 2000 Apr;11(4):268-70. Unique Identifier : AIDSLINE MED/20233048
Maitland JE; Maw R; Department of Genitourinary Medicine, Royal Victoria Hospital,; Belfast, UK.

Abstract: With the licensing of the new drug Imiquimod cream 5% (Aldara 3M Health Care) for the treatment of anogenital warts and its inclusion into clinic guidelines, a case note review audit was performed of its use. The treatment of 52 patients was audited. Results showed that clinic guidelines were being followed and that patient outcomes in terms of clearance were at least as good as the quoted rates in the literature. Significant issues included firstly patient education-especially for those who had previously received ablative therapy. Secondly the length of time that therapy would be continued before a patient was deemed to be a non-responder to Imiquimod cream 5%, and if this was the case should the frequency of application be amended from the manufacturer's recommended regime of 3 times a week.
Keywords: JOURNAL ARTICLE Adolescence Adult Aminoquinolines/*THERAPEUTIC USE Condylomata Acuminata/*DRUG THERAPY Female Human Male Medical Audit/*STATISTICS & NUMER DATA Middle Age Treatment Outcome

KWDjournalarticleadolescenceadultaminoquinolines/KWDtherapeuticusecondylomataacuminata/KWDdrugtherapyfemalehumanmalemedicalaudit/KWDstatistics&numerdatamiddleagetreatmentoutcome
000930
A0091500

Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .